The issue of Resistance Antibiotic resistance is a significant complicating factor that makes it significantly more difficult to treat such infections. More and more organisms are becoming resistant as a result of the significant increase in antibiotic prescriptions worldwide, both for infections in which antibiotics play no role or for infections that do not require antibiotics.

The tendency to stop taking antibiotics early, the inappropriate use of antibiotics by prescription or self-medication, taking inadequate doses of medication, glaring differences in the quality of the drugs used, and the failure to use culture results in treating UTIs are, without a doubt, the factors that contribute to the extremely high prevalence of resistance to some antibiotics.

Some bacterial strains can survive antibiotic treatment due to antibiotic resistance, making their eradication more challenging.

Antibiotics should be administered in accordance with current guidelines and continued for the full duration, regardless of symptom improvement, in order to avoid this.

UTIs are caused by bladder infections like cystitis, urethritis, and pyelonephritis, which is an infection of the kidneys and/or ureters. The majority of UTIs are caused by enterobacteriaceae, with uropathogenic Escherichia coli (UPEC) accounting for between 60 and 80 percent of cases.

Klebsiella, Enterobacter, Proteus, Enterococci, and some Staphylococcus species are additional significant UTI pathogens.

It is essential to diagnose and treat a UTI as soon as possible to avoid illness prolongation, ascending infection, and renal involvement. Consequently, antibiotic therapy for a UTI is primarily empirical until culture results are obtained.

In order to ensure that the treatment is appropriate in the majority of cases, the potential pathogen and its susceptibility pattern must be known in each region. With their reports of antibiotic sensitivity, this justifies regular studies of UTIs and the organisms that cause them.

For uncomplicated cystitis, resistance to common medications like nitrofurantoin and fosfomycin is the first line of treatment. In addition, Nitrofurantoin continues to be effective against UPEC in 77% to 90% of cases, but not against Staphylococcus and Klebsiella, which developed resistance in 58% of cases. Cotrimoxazole is another first-line antibiotic that is widely used, but several European studies have found that resistance is rising worldwide by up to 60%.

Ampicillin and amoxicillin were generally utilized, however above 85% of UPEC and Enterobacteriaceae and Staphylococci are impervious to the normal anti-infection ampicillin, while over 75% are impervious to amoxicillin.

Tetracycline, a broad-spectrum antibiotic, is resistant to over 70% of patients, while common cephalosporins are resistant to at least 60%.

While first-generation cephalosporins have mostly stopped working against UTI pathogens, second- and third-generation medications like cefixime have also been used too much, causing resistance to quickly develop in as many as two out of every three cases in developing nations.

However, other studies indicate that these antibiotics are still effective in more developed societies, with resistance ranging from 10% to 20%.

Nalidixic acid, a quinolone antibiotic, had a high rate of resistance, probably as a result of its extensive use to treat UTIs.

Similarly, ciprofloxacin resistance is significant and growing in developing nations (between 55% and 85%), making it ineffective as an empirical treatment for UTIs in individuals who have previously taken these medications.

In contrast, in developed nations, the majority of these pathogens continue to be susceptible to ciprofloxacin and other fluoroquinolones.  

eBook on microbiology: a compilation of the best interviews, news, and articles from the previous year.

Download the most recent version Chloramphenicol also maintains significant sensitivity even at resistance levels below 30%. While UPEC and Klebsiella are still sensitive to amikacin in the majority of cases (above 80-90%), gentamicin has lost favor due to high resistance levels (between 30% and 50%). There are regional variations in the frequency of resistance.

The majority, on the other hand, are sensitive to imipenem, which is still very effective against these pathogens. In many nations, it exhibits sensitivity of between 85 and 100 percent. This may be primarily because of its limited use, higher price, and intravenous injection requirement.

Through the use of plasmids, multidrug-resistant (MDR) Gram-negative bacteria (GNB) have rapidly acquired carbapenemases and extended-spectrum-lactamases (ESBLs). All beta-lactams and carbapenems are currently MDR for over half of UPEC strains and a third of Klebsiella strains.